Filing
Spy
Filing
Spy
Home
About
ALXN
Alexion Pharmaceuticals Inc
Alexion Pharmaceuticals Inc
CUSIP: 015351109
Healthcare
US
2 holders
Ownership
Activity
Fundamentals
2020 Q2
5 of 30 quarters
Total Value
$2.18M
Total Shares
19.4K
Net Share Change
+9.7K
Activity
1 buying
1 selling
Investor
Value
Shares
Weight
Change
Maverick Capital
$1.51M
13.4K
0.0%
ADD
+11.3K
(+534.0%)
Maverick Capital
$1.51M
13.4K shares
ADD
+11.3K
(+534.0%)
Pzena Investment Management
$672.0K
6.0K
0.0%
TRIM
-1.6K
(-21.4%)
Pzena Investment Management
$672.0K
6.0K shares
TRIM
-1.6K
(-21.4%)
ALXN — Alexion Pharmaceuticals Inc - FilingSpy